Finally, BML-111 exerts anti-inflammatory effects in a chronic obstructive pulmonary disease (COPD) mouse model by preventing NLRP3 inflammasome activation and inhibiting ROS production through NRF2 upregulation [180]. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.